Thromboembolic complications after splenectomy for hematologic diseases.
Thromboembolic complications following splenectomy for hematologic diseases occur in up to 10% of patients and may range from portal vein thrombosis (PVT) to pulmonary embolism (PE) and deep vein thrombosis (DVT). Up to now there exist no recommendations for the duration and intensity of prophylactic anticoagulation, which usually follows local institutional protocols. We report on three consecutive patients with severe portal vein thrombosis and/or pulmonary embolism--one with fatal outcome--7 to 35 days after splenectomy for autoimmune hemolytic anemia, immunothrombocytopenia, and indolent lymphoma, respectively. Incidence and pathophysiology of thromboembolic events (TE) in this patient group as well as prophylactic anticoagulation will be discussed, including a review of the current literature on this topic.
Mohren
Martin
M
Klinik für Hämatologie/Onkologie, Universität Magdeburg, Germany. Martin.Mohren@medizin.uni-magdeburg.de
Markmann
Ilka
I
Dworschak
Ulrike
U
Franke
Astrid
A
Maas
Christian
C
Mewes
Sabine
S
Weiss
Günter
G
Jentsch-Ullrich
Kathleen
K
D000328:Adult; D000743:Anemia, Hemolytic / Q000601:surgery; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000601:surgery; D008297:Male; D008875:Middle Aged; D011169:Portal Vein / Q000000981:diagnostic imaging; D011183:Postoperative Complications / Q000097:blood*; D011655:Pulmonary Embolism / Q000000981:diagnostic imaging / Q000188:drug therapy; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000601:surgery; D011859:Radiography; D013156:Splenectomy / Q000009:adverse effects*; D013923:Thromboembolism / Q000175:diagnosis* / Q000188:drug therapy; D014682:Vena Cava, Inferior / Q000000981:diagnostic imaging